Molina Q2 GAAP EPS $1.19, down 75% YoY; raises full-year guidance

MOLINA HEALTHCARE, INC.

Q2 2026 GAAP EPS $1.19 vs $4.75 YoY; adjusted EPS $1.51 vs $5.48 YoY.
Premium revenue $10.24B, down 5.7% YoY; total revenue $10.87B, down 4.8% YoY.
Medical care ratio 92.2% vs 90.4% YoY; G&A ratio 6.7% vs 6.2% YoY.
Net income $60M vs $255M YoY, a 76% decline.
Company raises full-year 2026 earnings guidance; specific numbers not in excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.